Leonteq Securities’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,063
Closed -$36K – 1374
2026
Q2
$36K Sell
1,063
-5,084
-83% -$169K ﹤0.01% 866
2026
Q1
$185K Buy
6,147
+4,061
+195% +$131K 0.01% 616
2025
Q4
$65.1K Sell
2,086
-12,600
-86% -$310K ﹤0.01% 905
2025
Q3
$297K Sell
14,686
-19,349
-57% -$340K 0.01% 525
2025
Q2
$570K Sell
34,035
-43,062
-56% -$695K 0.02% 362
2025
Q1
$1.19M Buy
77,097
+75,961
+6,687% +$1.36M 0.07% 216
2024
Q4
$25K Sell
1,136
-270
-19% -$4.91K ﹤0.01% 939
2024
Q3
$25.3K Sell
1,406
-3,534
-72% -$61.9K ﹤0.01% 883
2024
Q2
$80.3K Sell
4,940
-49,717
-91% -$766K 0.01% 665
2024
Q1
$771K Sell
54,657
-225,770
-81% -$2.85M 0.06% 254
2023
Q4
$2.93M Sell
280,427
-46,744
-14% -$436K 0.17% 122
2023
Q3
$3.34M Sell
327,171
-72,960
-18% -$679K 0.18% 122
2023
Q2
$3.01M Buy
400,131
+114,220
+40% +$926K 0.16% 148
2023
Q1
$2.53M Buy
+285,911
New +$2.83M 0.12% 158
2022
Q4
– Sell
-31,762
Closed -$277K – 1358
2022
Q3
$256K Sell
31,762
-97,063
-75% -$858K 0.01% 483
2022
Q2
$969K Sell
128,825
-92,932
-42% -$810K 0.04% 288
2022
Q1
$2.08M Buy
221,757
+14,491
+7% +$121K 0.07% 196
2021
Q4
$1.66M Sell
207,266
-74,934
-27% -$676K 0.06% 250
2021
Q3
$2.75M Buy
282,200
+177,903
+171% +$1.67M 0.12% 149
2021
Q2
$1.03M Buy
104,297
+39,512
+61% +$418K 0.06% 262
2021
Q1
$748K Sell
64,785
-59,246
-48% -$679K 0.04% 317
2020
Q4
$1.2M Buy
+124,031
New +$1.19M 0.06% 244

Other funds holding TEVA

Leonteq Securities's TEVA Position: Q3 2026 in Review

Leonteq Securities sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 1,063 shares — an estimated $36K sold.

Leonteq Securities first reported a position in TEVA in Q4 2020 and held it in 22 quarters. The position peaked at $3.34M in Q3 2023. 595 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Leonteq Securities reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
  • Leonteq Securities sold 1,063 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $36K.
  • Leonteq Securities first reported a position in Teva Pharmaceutical Industries in Q4 2020 and held it in 22 quarters.
  • Leonteq Securities's Teva Pharmaceutical Industries position peaked at $3.34M in Q3 2023.
  • 595 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.